A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples